Transplant Diagnostics Market is likely to surpass US$10,139.38 Million Revenues by 2029
Global Transplant Diagnostics Market research report makes use of SWOT analysis and Porter’s Five Forces analysis to disclose the strengths, weaknesses, opportunities, and threats in the HELATH industry. This report is an important source of guidance for companies and individuals offering industry chain structure, business strategies and proposals for new project investments. Analysis and estimation of important industry trends, market size, and market share are mentioned in this market report. An influential Global Transplant Diagnostics Market business report proves to be an indispensable document for every market enthusiast, policymaker, investor, and player.
Pre-transplant and post-transplant procedures are the typical divisions for the diagnostic process known as transplant diagnosis. The immunocompromised person runs the risk of contracting HAI or worse, which can be fatal, if this isn’t avoided. Better patient outcomes are ensured by the procedure, which is a successful collaboration between medical professionals and laboratory experts. Furthermore, it’s critical that the HLA markers of the donor and recipient closely match. This raises the possibility of graft survival and reduces the likelihood of immunological transplantation-related serious complications. Throughout the anticipated years, market expansion is likely to be fueled by the rising prevalence of chronic illnesses among the global population. Additionally, stem cell therapy and customized medicines are becoming more and more popular.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-transplant-diagnostics-market&Shri
Data Bridge Market Research analyzes that the global transplant diagnostics market is expected to reach a value of USD 10,139.38 million by 2029, at a CAGR of 6.8% during the forecast period. Product type accounts for the largest segment in the market due to the rapid demand for transplant diagnostics globally. This market report also covers pricing analysis, patent analysis and technological advancements in depth.
Market Overview:
Transplant diagnostics are the immunogenetics and histocompatibility of organ and hematopoietic stem cell transplantations. These diagnostics help healthcare professionals determine compatibility between potential recipients and organ donors. These are used in various disciplines, such as immunogenetics, pathology and infectious diseases, among others. Transplant diagnostics are used to determine whether the donor and the recipient of the organ are compatible before or after the transplant. With the introduction of transplant diagnostics, the prevalence of diseases that can cause organ failure, including both pre-and post-transplant screening, is expected to explode. The market has attracted the interest of healthcare professionals due to the many advantages these tests offer to verify suitability for a transplant procedure. Organ transplantation is one of the most popular treatment options for many end-stage renal disease patients on continuous dialysis.
Transplant diagnosis is a diagnostic procedure usually divided into pre-transplant and post-transplant procedures. It helps to analyze the health status of the patient. If this is avoided, the immunocompromised person is at risk of developing HAI or worse, which can lead to death. The procedure is a harmonious collaboration between healthcare professionals and laboratory experts, ensuring better patient outcomes. In addition, close matching of donor and recipient HLA markers is important. This increases the likelihood of graft survival and minimizes serious complications of immunological transplantation. The increased prevalence of chronic illnesses among the worldwide population is likely to drive market expansion throughout the forecast years. Furthermore, the increasing use of stem cell therapy and personalized medications is gaining popularity. The use of new diagnostic techniques has improved the medical outcomes of organ transplants. The rate of organ rejection can be reduced by matching the compatibility of the donor and recipient before transplantation.
Increasing focus on personalized medicine is expected to drive the market’s growth rate
In the field of transplantation, personalized medicine has become increasingly important. Transplant diagnostics play a crucial role in this approach by identifying specific genetic markers and immune profiles of individuals. This information helps in tailoring treatment plans and optimizing patient outcomes. By providing a personalized approach to transplantation, transplant diagnostics contribute to improved patient care and treatment efficacy. This focus on personalized medicine is driving the growth of the transplant diagnostics market as healthcare providers recognize its value in enhancing transplant outcomes.
Drivers
- Rising number of transplant procedures
The demand for organ transplantation has rapidly increased worldwide during the past decade due to the increased incidence of vital organ failure and improved post-transplant outcomes. Demand for kidney, heart, liver and lungs transplant is very high. Alcohol consumption, lack of exercise and drug abuse are leading causes of organ failure. The number of living donor transplants has been affected by the COVID-19 pandemic. But living donor transplants have increased by 14.2 percent over 2020.
- In addition, organ transplantation improves patient survival and quality of life and has a major positive impact on public health and the socioeconomic burden of organ failure. The European Union (EU) has a relatively uniform and structured approach to organ transplantation, well-developed national programs, international systems to facilitate organ sharing and well-defined exchange policies, making Europe a leader in this field.
Thus, the increasing number of transplant procedures across the globe and the increase in successful transplantations is expected to boost the global transplant diagnostics market.
- Increase in the technological advancements in the field of transplants
New technologies are rapidly changing traditional approaches to organ transplantation. The main challenges in organ transplantation are how best to identify and, if possible, eliminate the need for lifelong immunosuppression and how to expand the pool of donors suitable for human transplantation. Researchers have developed an advanced system where transport time can be extended by tricking donor organs into thinking they are still inside the body. This system keeps oxygenated blood flowing through the organs to delay tissue death. A normothermic perfusion machine mimics the human body, ensuring constant blood flow to the organ. The machine can also deliver drugs or other nutrients to keep the liver in optimal condition before the transplant.
Recent Developments
- In August 2022, QIAGEN announced the publication in the Journal of Molecular Pathology of an externally facilitated clinical NGS interpretation validation study, demonstrating that its clinical decision support software, QIAGEN Clinical Insight Interpret One (QCI Interpret One), achieved a higher level of concordance with a panel of experts than human reviewers achieved amongst each other. The study commissioned by QDI and carried out independently by Genomics Quality Assessment (GenQA) investigated the classification of variants reported from oncology patient samples. This has helped the company to validate its research
- In January 2022, Hoffmann-La Roche Ltd introduced Cobas Infinity edge, a cloud-based point-of-care platform accessible globally. With its advanced technology, healthcare practitioners can handle patient data. This has helped the company to diversify its product line
Report Scope and Market Segmentation
| Report Metric | Details |
| Forecast Period | 2022 to 2029 |
| Base Year | 2021 |
| Historic Years | 2020 (Customizable to 2014-2019) |
| Quantitative Units | Revenue in USD Million, Volumes in Units, Pricing in USD |
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-transplant-diagnostics-market?Shri
Major Players
Data Bridge Market Research recognizes the following companies as the major transplant diagnostics market players in transplant diagnostics market are Hologic, Inc. (U.S.), Biofortuna Limited (U.K.), Takara Bio Inc. (Japan), Abbott (U.S.), Diagnóstica Longwood SL (Spain), Adaptive Biotechnologies (U.S.), NanoString (U.S.), Arquer Diagnostics Ltd (U.K.), altona Diagnostics GmbH (Germany), ELITechGroup (France)
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the this research report
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
Top Key Topics Covered:
- Strategic Imperatives
- Factors Creating Pressure on Growth
- The Strategic Imperative
- Growth Opportunities Fuel the Growth Pipeline Engine
- Research Methodology
- Scope and Segmentation
- Research Context and Scope of Analysis
- Segmentation
- Other Techniques for This Research Report Management
- Growth Opportunity Analysis
- Growth Drivers
- Growth Restraints
- Introduction
- The Impact of the COVID-19 Pandemic and Post
- Future Growth
- Innovation Ecosystem
Continued…
Segment Analysis:
The transplant diagnostics market is segmented on the basis of product type, technology, transplant type, application, end user, and distribution channel.
- On the basis of product type, the global transplant diagnostics market is segmented into transplant diagnostic instrument, transplant diagnostic software, and transplant diagnostic reagent. Transplant diagnostic instrument segment is expected to dominate the global transplant diagnostics market with a CAGR of 8.3% in the forecast period of 2022 to 2029 due to the rise in transplantation procedures all over the world.
In 2022, the transplant diagnostic instrument segment is expected to dominate the product type segment of the global transplant diagnostics market
In 2022, the transplant diagnostic instrument segment is expected to dominate the global transplant diagnostics market owing to specialized instruments used for performing various diagnostic tests and procedures related to transplantation. These instruments can include molecular diagnostic platforms, flow cytometers, next-generation sequencing (NGS) systems, and histocompatibility testing equipment. These instruments help in analyzing genetic markers, immune profiles, and compatibility between donors and recipients with a CAGR of 8.3% in the forecast period of 2022 to 2029.
- On the basis of technology, the global transplant diagnostics market is segmented into PCR-based molecular assays, and sequencing-based molecular assays. Into PCR-based molecular assays segment is expected to dominate the global transplant diagnostics market and is expected to reach USD 7,174.72 million by 2029 in the forecast period of 2022 to 2029 due to increased technological advancement in the transplant procedure.
- On the basis of transplant type, the global transplant diagnostics market is segmented into solid organ transplantation, stem cell transplantation, soft tissue transplantation, bone marrow transplantation, and other transplants. The solid organ transplantation segment is expected to dominate the global transplant diagnostics market with a CAGR of 10.0% in the forecast period of 2022 to 2029 due to the rise in the number of types of organ transplants in the healthcare industry.
In 2022, the solid organ transplantation segment is expected to dominate the transplant-type segment of the global transplant diagnostics market
In 2022, the solid organ transplantation segment is expected to dominate the global transplant diagnostics market owing to various reasons such as chronic diseases, congenital abnormalities, or trauma. The procedure involves removing the diseased organ(s) from the recipient and replacing it with a compatible organ from a deceased or living donor with a CAGR of 10.0% in the forecast period of 2022 to 2029.
- On the basis of application, the global transplant diagnostics market is segmented into diagnostic applications and research applications. Diagnostic applications segment is expected to dominate the global transplant diagnostics market with a CAGR of 6.8% in the forecast period of 2022 to 2029 due to increased strategic collaboration between key market players.
- On the basis of end user, the global transplant diagnostics market is segmented into research laboratories and academic institutes, hospitals and transplant centers, commercial service providers, and others. Hospitals and transplant centers segment is expected to dominate the global transplant diagnostics market with a CAGR of 7.4% in the forecast period of 2022 to 2029 due to rising transplant surgeries in hospitals and transplant centers.
- On the basis of distribution channel, the global transplant diagnostics market is segmented into direct tender, retail sales, and others. Direct tender segment is expected to dominate the global transplant diagnostics market a CAGR of 7.3% in the forecast period of 2022 to 2029 due to the production of transplant diagnostics equipment and services in the market.
Browse Detailed Summary of Research Report with TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-transplant-diagnostics-market&Shri
Some of the Most Important Questions Scrutinized in the Business Intelligence Report:
- What are the key growth parameters for this global market during the forecast period?
- Which key players are expected to hold the largest market share over the forecast period?
- Who are the leading vendors and manufacturers in this market?
- What are the key strategies adopted by leading players in the market for business development and geographical expansion?
- Which end-use industries can trigger high demand in the market over the forecast period?
- What are the key segments in this market?
- Which regional player will have anticipated leading the global market in terms of size?
- What is the impact of the novel coronavirus pandemic?
- Which obstacles must new players overcome in order to occupy a major position?
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- The Wire Times
